STRAGEN NORDIC A/S: Financial statements 2014
CVR: 26717825
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,272,586 and a net result of DKK 171,247 compared with DKK -292,716 the year before. That is a decrease of 6.8% compared with the year before. Equity in the 2014 report amounted to DKK 2,846,986. The solvency ratio was 23.4%.
- Gross Profit
- DKK 4,272,586
- Profit/Loss
- DKK 171,247
- Equity
- DKK 2,846,986
- Total Assets
- DKK 12,162,333
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 4.3M | 171K | 2.8M | - |
| 2013 | - | 4.6M | -293K | 2.7M | - |
| 2012 | 39.5M | 2.1M | -2.8M | 3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
STRAGEN NORDIC A/S has published its annual report for 2013. Gross profit came to DKK 4,586,066, and the net result was DKK -292,716.
As of April 23, 2014, Jean-Luc Tetard has joined the board of directors of STRAGEN NORDIC A/S.
As of April 23, 2014, Yves Josef Gaby Decadt has left the board of directors of STRAGEN NORDIC A/S.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.